Immune Checkpoint Inhibitors in Head and Neck Cancer: Understanding the Current Evidence and Future Directions

Download All

Download slidesets and review an archived webcast from a live symposium in which 3 experts discussed the rationale for checkpoint inhibition in advanced HNSCC, provided practical guidance on clinical use, and assessed promising near-future immunotherapies for HNSCC. Review key points for HNSCC treatment with a downloadable resource guide.

Barbara Burtness, MD
Program Director

PDF

Review key points for using immune checkpoint inhibitors for HNSCC treatment with this downloadable resource guide.

Barbara Burtness, MD
Program Director
Released: June 25, 2019
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Merck & Co., Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings